Avalara Survey: Finance Leaders are Racing to Deploy AI Agents Before Governance is Ready
Nine in 10 finance leaders say they are under pressure to prove AI ROI, while only 7% say their organizations prioritize governance over deployment speed DURHAM,... Read more.
Meet CIRQA Smart Band: The screen-free health and fitness tracker from Garmin
Distraction-free design provides comprehensive 24/7 health monitoring and activity tracking—no subscription required OLATHE, Kan., July 21, 2026 /PRNewswire/ —... Read more.
Compugen to Participate in BTIG Biotechnology Conference 2026
HOLON, Israel, July 21, 2026 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational... Read more.
RADCOM to Report Second Quarter 2026 Results on Wednesday, August 12, 2026
Conference Call Scheduled for 8:00 a.m. Eastern Time (3:00 p.m. Israel Time) TEL AVIV, Israel, July 21, 2026 /PRNewswire/ — RADCOM Ltd. (NASDAQ: RDCM) announced... Read more.
Compass, Inc. to Announce Second Quarter Results on August 4
NEW YORK, July 21, 2026 /PRNewswire/ — Compass, Inc., d/b/a Compass International Holdings (the “Company”) (NYSE: COMP), a global real estate services... Read more.
NorthRock Partners Expands Minneapolis Presence with Addition of Kowalski Financial, Strengthening National Growth Strategy
The partnership expands NorthRock’s Personal Office® model in its hometown of Minneapolis while bringing additional expertise and resources to Kowalski Financial’s... Read more.
Imagine360 and Health Rosetta Launch Integrated Health Plan for Employers Facing Record Cost Increases
Joint offering follows Imagine360’s completion of Health Rosetta’s Embedded Solutions evaluation process, giving advisors a turnkey solution built... Read more.
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
SHANGHAI, July 21, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited (“Alebund” or the “Company”; HKEX: 09637), a renal-focused... Read more.
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
Dr. Haumann brings decades of respiratory drug expertise to support next phase of company growth CEO appointment follows recent clinical and corporate milestones... Read more.
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
Two global registrational Phase 3 trials initiated in ZENITH AD program Phase 3 program based upon clinically meaningful efficacy and favorable safety data observed... Read more.